Pros and cons of docetaxel used to treat metastatic hormone-sensitive prostate cancer: The cons

被引：0
|
作者：
Suzuki, Kazuhiro [1 ]
机构：
[1] Gunma Univ, Grad Sch Med, Dept Urol, Maebashi, Gunma, Japan
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
WS-1-2
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Docetaxel for hormone-sensitive metastatic prostate cancer
    Baker, Holly
    LANCET ONCOLOGY, 2015, 16 (09): : E432 - E432
  • [2] Docetaxel Improves Survival in Metastatic Hormone-Sensitive Prostate Cancer
    Schuyler, Devon
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (09) : 549 - 549
  • [3] Management of Metastatic Hormone-Sensitive Prostate Cancer: Is Docetaxel Needed?
    Kartolo, Adi
    Tannock, Ian F.
    Badillo, Francisco E. Vera
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (31) : 3573 - +
  • [4] How I Treat Metastatic Hormone-Sensitive Prostate Cancer?
    Dabkara, Deepak
    Mondal, Debapriya
    Ghosh, Joydeep
    Biswas, Bivas
    Ganguly, Sandip
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2021, 42 (01) : 100 - 107
  • [5] Effectiveness of Docetaxel for Metastatic Hormone-sensitive Prostate Cancer in Clinical Practice
    Lendorf, Maria Elisabeth
    Petersen, Peter Meidahl
    Svendsen, Andrea Steen
    Lindberg, Henriette
    Brasso, Klaus
    EUROPEAN UROLOGY OPEN SCIENCE, 2021, 24 : 25 - 33
  • [6] Docetaxel Treatment for Metastatic Hormone-sensitive Prostate Cancer in Daily Practice
    de Groot, Ietsen
    Brinkman, Ithamar
    Luijendijk-de Bruin, Daphne
    Poort, Sharon
    van Rooijen, Johan M.
    EUROPEAN UROLOGY OPEN SCIENCE, 2021, 33 : 48 - 55
  • [7] Metastatic hormone-sensitive prostate cancer
    Gravis, Gwenaelle
    Salem, Naji
    Walz, Jochen
    BULLETIN DU CANCER, 2015, 102 (01) : 57 - 64
  • [8] Pros and cons of pelvic lymphadenectomy in prostate cancer
    Heidenreich, A
    AKTUELLE UROLOGIE, 2004, 35 (01) : 28 - 32
  • [9] Outcomes of older men receiving docetaxel for metastatic hormone-sensitive prostate cancer
    Lage, Daniel E.
    Michaelson, Dror M.
    Lee, Richard J.
    Greer, Joseph A.
    Temel, Jennifer S.
    Sweeney, Christopher
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [10] Early docetaxel-resistance in metastatic hormone-sensitive prostate cancer.
    Bukhari, Nedal
    Potvin, Kvica R.
    Ernst, D. Scott
    Sax, Lori
    Winquist, Eric
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
12345